Brief: Hemogenyx Pharma Receives Investment From Prevail Partners

Hemogenyx Pharmaceuticals

18/09/2023 07:37

Sept 18 (Reuters) - Hemogenyx Pharmaceuticals PLC
 HEMO.L :
    * HEMOGENYX PHARMA PLC  - STRATEGIC INVESTMENT FROM PREVAIL
PARTNERS, LLC
    * HEMOGENYX PHARMACEUTICALS PLC - PREVAIL PARTNERS TO INVEST
IN CO
VIA SUBSCRIPTION FOR 11.1 MILLION SHARES AT $0.075/SHARE FOR
TOTAL SUM OF $830,000

Source text for Eikon:  ID:nRSR6805Ma 
Further company coverage:  HEMO.L 

 ((Reuters.Briefs@thomsonreuters.com;))